| Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility A Schroeder, Y Avnir, S Weisman, Y Najajreh, A Gabizon, Y Talmon, ... Langmuir 23 (7), 4019-4025, 2007 | 277 | 2007 |
| Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution XC Tang, SS Agnihothram, Y Jiao, J Stanhope, RL Graham, EC Peterson, ... Proceedings of the National Academy of Sciences 111 (19), E2018-E2026, 2014 | 274 | 2014 |
| IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity Y Avnir, CT Watson, J Glanville, EC Peterson, AS Tallarico, AS Bennett, ... Scientific reports 6 (1), 20842, 2016 | 177 | 2016 |
| Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses Y Avnir, AS Tallarico, Q Zhu, AS Bennett, G Connelly, J Sheehan, J Sui, ... PLoS pathogens 10 (5), e1004103, 2014 | 128 | 2014 |
| Amphipathic weak acid glucocorticoid prodrugs remote‐loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: A novel approach to … Y Avnir, R Ulmansky, V Wasserman, S Even‐Chen, M Broyer, ... Arthritis & Rheumatism 58 (1), 119-129, 2008 | 124 | 2008 |
| pH determination by pyranine: medium-related artifacts and their correction Y Avnir, Y Barenholz Analytical biochemistry 347 (1), 34-41, 2005 | 92 | 2005 |
| A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve Y Fu, Z Zhang, J Sheehan, Y Avnir, C Ridenour, T Sachnik, J Sun, ... Nature communications 7 (1), 12780, 2016 | 82 | 2016 |
| Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids Y Avnir, K Turjeman, D Tulchinsky, A Sigal, P Kizelsztein, D Tzemach, ... PloS one 6 (10), e25721, 2011 | 77 | 2011 |
| Structural determination of the broadly reactive anti-IGHV1-69 anti-idiotypic antibody G6 and its idiotope Y Avnir, KL Prachanronarong, Z Zhang, S Hou, EC Peterson, J Sui, ... Cell reports 21 (11), 3243-3255, 2017 | 21 | 2017 |
| Use of liposomal glucocorticoids for treating inflammatory states Y Barenholz, Y Naparstek, Y Avnir, R Ulmansky US Patent 7,744,920, 2010 | 10 | 2010 |
| Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLL DK Chang, VB Kurella, S Biswas, Y Avnir, J Sui, X Wang, J Sun, Y Wang, ... MAbs 8 (4), 787-798, 2016 | 9 | 2016 |
| Humanized monoclonal antibodies and methods of use WA Marasco, J Sui, Y Avnir US Patent 9,527,924, 2016 | 6 | 2016 |
| Use of liposomal glucocorticoids for treating inflammatory states Y Barenholz, Y Naparstek, Y Avnir, R Ulmansky | 5 | 2006 |
| A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve. Nat Commun 7: 12780 Y Fu, Z Zhang, J Sheehan, Y Avnir, C Ridenour, T Sachnik, J Sun, ... | 4 | 2016 |
| Liposomal compositions of glucocorticoid and glucocorticoid derivatives Y Barenholz, AA Gabizon, Y Avnir US Patent 8,932,627, 2015 | 4 | 2015 |
| Humanized monoclonal antibodies and methods of use WA Marasco, J Sui, Y Avnir US Patent 10,179,822, 2019 | 3 | 2019 |
| Immunogenetic restriction on elicitation of antibodies W Marasco, Y Avnir | 2 | 2015 |
| Liposomal compositions of glucocorticoid and glucocorticoid derivatives Y Barenholz, AA Gabizon, Y Avnir US Patent App. 14/560,045, 2015 | 2 | 2015 |
| Amphipathic Weak Acid Glucocorticoid-prodrugs Remote Loaded Into Nanoliposomes: From Physicochemical Principles to Therapeutic Efficacy Y Avnir Hebrew University of Jerusalem, 2007 | 1 | 2007 |
| Liposomal compositions of glucocorticoid and glucocorticoid derivatives Y Barenholz, AA Gabizon, Y Avnir | 1 | 2006 |
